In a promising development for those affected by Hepatitis B, researchers have reported that a drug called bepirovirsen has made the virus undetectable in about 20% of patients, maintaining this result nearly a year after treatment. This breakthrough, published in the New England Journal of Medicine, involved over 18,000 patients across 29 countries. The drug’s manufacturer is now seeking approval from the Food and Drug Administration, with a decision expected by late October.

Eli Lilly’s Strategic Vaccine Investment

Eli Lilly, a pharmaceutical giant known for its treatments in diabetes, weight loss, cancer, and Alzheimer’s, is making a significant move back into the vaccine sector. The company has announced plans to invest up to $4 billion in acquiring three biotech firms that are developing vaccines for shingles, staph infections, and the Epstein-Barr virus. Although these companies have yet to bring products to market, Eli Lilly’s investment marks a major strategic shift, potentially expanding its influence in the vaccine industry.

Managing Summer Anxiety for Families

As summer approaches and schools let out, many parents face the challenge of keeping their children entertained without feeling overwhelmed. Experts from Cleveland Clinic Children’s advise that parents shouldn’t feel pressured to fill every moment of their children’s time. Allowing kids to experience boredom can foster creativity and imagination. Additionally, budget-friendly activities such as visiting splash pads, libraries, and participating in backyard bonfires can provide entertainment without financial strain. Museums and zoos often offer free or discounted admission days, and moderate screen time is acceptable as long as it’s balanced with outdoor activities. Parents experiencing persistent anxiety are encouraged to consult with mental health professionals.

Original reporting: WQAD (Quad Cities) — read the source article.